SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001725160-23-000035
Filing Date
2023-02-14
Accepted
2023-02-14 19:10:55
Documents
1
Period of Report
2023-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167641983783824.html 4  
1 FORM 4 wf-form4_167641983783824.xml 4 5884
  Complete submission text file 0001725160-23-000035.txt   7444
Mailing Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Issuer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ZENTALIS PHARMACEUTICALS, INC. 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018
Business Address
Epperly Melissa B, (Reporting) CIK: 0001807359 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39263 | Film No.: 23632794